Table 2.
Multivariate cox regression analysis of factors associated with OS in ESCC
Variable | Training group (n = 93) | Test group (n = 102) | ||||
---|---|---|---|---|---|---|
95% CI | RR | P | 95% CI | RR | P | |
Sex (male vs. female) | 0.194–1.405 | 0.522 | 0.198 | 0.268–1.214 | 0.570 | 0.145 |
Age (≤60 vs. > 60 years) | 0.796–2.877 | 1.514 | 0.206 | 0.573–1.674 | 0.980 | 0.940 |
Tumor size (≤5 cm vs. > 5 cm) | 0.667–2.119 | 1.189 | 0.558 | 0.396–1.229 | 0.698 | 0.213 |
Tumor stages (T1 + T2 vs. T3+ T4) | 0.643–3.247 | 1.445 | 0.373 | 0.555–2.548 | 1.189 | 0.656 |
Histologic grade (Well/ moderate vs. Poor/NS) |
0.880–3.517 | 1.759 | 0.110 | 0.491–1.852 | 0.954 | 0.889 |
Lymph node metastasis (negative vs. positive) |
0.109–4.526 | 0.702 | 0.709 | 0.306–1.951 | 0.773 | 0.586 |
Clinical stages (I + II vs. III + IV) | 0.297–12.497 | 12.806 | 0.487 | 0.616–4.530 | 1.670 | 0.314 |
miR-10b-3p expression levels (Low vs. High) |
1.355–7.062 | 3.093 | 0.007 | 1.678–7.913 | 3.644 | 0.001 |